Close

Analyst Ratings for Harpoon Therapeutics (HARP) [Buys]

HARP Rating Summary

HARP Price Target Summary

* Over Last 12-Mos
  |   Expand Research on HARP
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $21.86 (-5%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 42%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/5/2024 Oppenheimer Hartaj Singh New Coverage Outperform
(N/A)
23.00
(N/A)
10.53
(23.01)
118.52% Details
7/6/2022 Canaccord Genuity
» Updated 10/24/2023
William Maughan New Coverage Buy
(N/A)
30.00
(40.00)
2.02
(23.01)
1039.11% Details